Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Guardant Health Inc (NQ: GH )

23.00 +1.12 (+5.12%)
Streaming Delayed Price Updated: 4:00 PM EDT, Nov 1, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Guardant Health Inc

< Previous 1 2
...
6 7 8 9 10 11 12 13 Next >
Guardant Health to Present New Data from its Broad Portfolio of Blood Tests at 2022 American Society of Clinical Oncology (ASCO) Annual Meeting
From Guardant Health, Inc.
Via Business Wire
Guardant Health Presents New Data Showing Blood Test Accuracy in Detecting Colorectal Cancer in First-of-its Kind Prospective Study at Digestive Disease Week 2022
From Guardant Health, Inc.
Via Business Wire
10 Biggest Price Target Changes For Monday
Morgan Stanley cut Guardant Health, Inc. (NASDAQ: GH) price target from $120 to $85. Guardant Health shares rose 4.3% to $40.99 in pre-market trading. 
Via Benzinga
What 6 Analyst Ratings Have To Say About Guardant Health
Over the past 3 months, 6 analysts have published their opinion on Guardant Health (NASDAQ:GH) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a... 
Via Benzinga
Recap: Guardant Health Q4 Earnings
Guardant Health (NASDAQ:GH) reported its Q4 earnings results on Wednesday, February 23, 2022 at 04:03 PM. Here's what investors need to know about the announcement. Earnings... 
Via Benzinga
90 Biggest Movers From Yesterday
Gainers 
Via Benzinga
92 Biggest Movers From Friday
Gainers Sidus Space, Inc. (NASDAQ: SIDU) jumped 51.8% to settle at $2.99 on Friday after the company announced a a memorandum of understanding with Dhruva Space to expand its partnership to further the... 
Via Benzinga
55 Stocks Moving In Friday's Mid-Day Session
Gainers Swvl Holdings Corp. (NASDAQ: SWVL) surged 24.4% to $7.50. Swvl Holdings 13D Filing from investor Ahmed Sabbah showed a new 6.4% stake in the company. 
Via Benzinga
Guardant Health Reports First Quarter 2022 Financial Results
From Guardant Health, Inc.
Via Business Wire
Guardant Health Announces Shield™ Blood Test Available in US to Detect Early Signs of Colorectal Cancer in Average-Risk Adults
From Guardant Health, Inc.
Via Business Wire
Guardant Health to Participate in the BofA Securities 2022 Healthcare Conference
From Guardant Health, Inc.
Via Business Wire
Guardant Health to Report First Quarter Financial Results on May 5, 2022
From Guardant Health, Inc.
Via Business Wire
Guardant Health Presents New Data Showing Blood Test Highly Accurate in Detecting Multiple Cancers at the American Association for Cancer Research Annual Meeting
From Guardant Health, Inc.
Via Business Wire
10 Health Care Stocks With Whale Alerts In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
Guardant Health Announces Partnership with Epic to Streamline Access to Company’s Broad Portfolio of Cancer Tests
From Guardant Health, Inc.
Via Business Wire
Guardant Health Response to Frivolous and Retaliatory Lawsuit Filed by Illumina
From Guardant Health, Inc.
Via Business Wire
Guardant Health Receives Regulatory Approval for Guardant360® CDx in Japan
From Guardant Health, Inc.
Via Business Wire
Guardant Health's Return On Capital Employed Overview
According to data from Benzinga Pro, during Q4, Guardant Health's (NASDAQ:GH) reported sales totaled $108.11 million. Despite a 32.75% increase in earnings, the company posted a... 
Via Benzinga
10 Biggest Price Target Changes For Thursday
SVB Leerink lowered Guardant Health, Inc. (NASDAQ: GH) price target from $170 to $140. Guardant Health shares dropped 5.7% to $56.22 in pre-market trading. 
Via Benzinga
Guardant Health Reports Fourth Quarter 2021 Financial Results and Provides 2022 Outlook
From Guardant Health, Inc.
Via Business Wire
The Daily Biotech Pulse: Kodiak Sinks On Adverse Study Outcome, Marinus Flags Delay In Clinical Trial, Mainz Biomed Gains On Positive Regulatory Development
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Kodiak's Wet AMD Treatment KSI-301 Did Not Meet Primary Endpoint In Phase... 
Via Benzinga
The Week Ahead In Biotech (Feb. 20-26): Reata Awaits FDA Decision, Bausch Health, Moderna Lead Earnings News Flow
Biotech stock extended lower for a second straight week as risk aversion continued to pressure stocks amid geopolitical tensions and macroeconomic worries. On the regulatory front... 
Via Benzinga
Guardant Health to Participate in Upcoming Investor Conferences
From Guardant Health, Inc.
Via Business Wire
Guardant Health to Report Fourth Quarter and Full Year 2021 Financial Results on February 23, 2022
From Guardant Health, Inc.
Via Business Wire
Guardant Health to Present Data Highlighting the Clinical Utility of Its Liquid Biopsy Tests in Gastrointestinal Cancers at ASCO GI Cancers Symposium
From Guardant Health, Inc.
Via Business Wire
Guardant Health Enrolls First Patient in SHIELD LUNG Study to Evaluate Accuracy of Its Blood Test to Detect Lung Cancer in High-Risk Adults
From Guardant Health, Inc.
Via Business Wire
Guardant Health and Foundation Medicine Reach Settlement in Digital Sequencing Technology Litigation
From Guardant Health, Inc.
Via Business Wire
Why Jim Cramer Likes Vertiv And Scotts Miracle-Gro
On CNBC’s "Mad Money Lightning Round," Jim Cramer said he likes Vertiv Holdings Co (NYSE: 
Via Benzinga
Guardant Health to Participate Virtually in the 40th Annual J.P. Morgan Healthcare Conference
From Guardant Health, Inc.
Via Business Wire
Guardant Health Reaches Target Enrollment of 12,750 Patients in ECLIPSE Pivotal Study for its LUNAR™-2 Blood Test to Detect Colorectal Cancer
From Guardant Health, Inc.
Via Business Wire
< Previous 1 2
...
6 7 8 9 10 11 12 13 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.